LSL-90202

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameLSL-90202
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen Pharma Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen Pharma Sas
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A